CB vs GRCE · P/E 14, rev $59.40B vs $35.0M cap
Chubb Ltd (CB) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
GRCE does not have a complete income-statement cache yet.
CB currently screens at market cap $114.26B and trailing P/E 13.7. GRCE currently screens at market cap $35.0M.
Not investment advice. Open the CB and GRCE stock pages for the full models.
Not investment advice.